Heart failure in pregnancy

被引：15

作者：

Rutherford J.D. ^{[1
]}

机构：

[1] UT Southwestern Medical Center, Dallas

来源：

Current Heart Failure Reports | 2012年 / 9卷 / 4期

关键词：

Heart failure; Mitral stenosis; Peripartum cardiomyopathy; Preeclampsia; Pregnancy;

D O I：

10.1007/s11897-012-0105-9

中图分类号：

学科分类号：

摘要：

With increasing maternal age and the presence of comorbid conditions such as hypertension, cardiovascular assessment and monitoring is the responsibility of all clinicians caring for pregnant patients. Furthermore, there are specific conditions, such as mitral stenosis, peripartum cardiomyopathy, and preeclampsia, that can be associated with heart failure and secondary maternal (and fetal) mortality and morbidity. The important causes of heart failure in pregnancy are discussed. © Springer Science+Business Media, LLC 2012.

引用

页码：277 / 281

页数：4

共 34 条

[21]

Sliwa K., Forster O., Libhaber E., Fett J.D., Sundstrom J.B., Hilfiker-Kleiner D., Ansari A.A., Peripartum cardiomyopathy: Inflammatory markers as predictors of outcome in 100 prospectively studied patients, European Heart Journal, 27, 4, pp. 441-446, (2006)

[22]

Sliwa K., Skudicky D., Candy G., Bergemann A., Hopley M., Sareli P., The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy, European Journal of Heart Failure, 4, 3, pp. 305-309, (2002)

[23]

Hilfiker-Kleiner D., Kaminski K., Podewski E., Et al., A cathepsin d-cleaved 16 kda form of prolactin mediates postpartum cardiomyopathy, Cell., 128, pp. 589-580, (2007)

[24]

Sliwa K., Blauwet L., Tibazarwa K., Et al., Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof-of-concept pilot study, Circulation, 121, pp. 1465-1463

[25]

Yamac H., Bultmann I., Sliwa K., Hilfiker-Kleiner D., Prolactin: A new therapeutic target in peripartum cardiomyopathy, Heart, 96, pp. 1352-1357

[26]

Felker G.M., Thompson R.E., Hare J.M., Et al., Underlying causes and long-Term survival in patients with initially unexplained cardiomyopathy, N Engl J Med., 342, pp. 1077-1074, (2000)

[27]

Elkayam U., Tummala P.P., Rao K., Et al., Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy, N Engl J Med., 344, pp. 1567-1561, (2001)

[28]

Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., Lang R.M., Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function, Am J Obstet Gynecol., 176, pp. 189-185, (1997)

[29]

Cunningham F.G., Pritchard J.A., Hankins G.D., Anderson P.L., Lucas M.J., Armstrong K.F., Peripartum heart failure: Idiopathic cardiomyopathy or compounding cardiovascular events?, Obstet Gynecol., 67, pp. 157-158, (1986)

[30]

Zinaman M., Rubin J., Lindheimer M.D., Serial plasma oncotic pressure levels and echoencephalography during and after delivery in severe pre-eclampsia, Lancet, 1, 8440, pp. 1245-1247, (1985)

← 1 2 3 4 →